These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 26401075)
21. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway. Chen M; Xing J; Pan D; Peng X; Gao P Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450 [TBL] [Abstract][Full Text] [Related]
22. [Effect of total flavones of hawthorn leafonon expression of COX-2/Nrf2 in liver of rats with nonalcoholic steatohepatitis]. Li XD; Chen ZY; Yu JS; Wang DJ; Yan MX Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):711-715. PubMed ID: 28871698 [TBL] [Abstract][Full Text] [Related]
23. Triptolide-induced hepatotoxicity can be alleviated when combined with Panax notoginseng saponins and Catapol. Zhou L; Zhou C; Feng Z; Liu Z; Zhu H; Zhou X J Ethnopharmacol; 2018 Mar; 214():232-239. PubMed ID: 29277608 [TBL] [Abstract][Full Text] [Related]
24. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction. Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558 [TBL] [Abstract][Full Text] [Related]
25. Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats. Wang DJ; Cai YQ; Pan SZ; Zhang LZ; Chen YX; Chen FM; Jin M; Yan MX; Li XD; Chen ZY Chin J Integr Med; 2018 Apr; 24(4):265-271. PubMed ID: 26919834 [TBL] [Abstract][Full Text] [Related]
26. Acetyl-l-carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats. Bodaghi-Namileh V; Sepand MR; Omidi A; Aghsami M; Seyednejad SA; Kasirzadeh S; Sabzevari O Environ Toxicol Pharmacol; 2018 Mar; 58():11-20. PubMed ID: 29278859 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation. Li H; Ying H; Hu A; Hu Y; Li D Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350 [TBL] [Abstract][Full Text] [Related]
28. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. Xu X; Wang W; Lin L; Chen P Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722 [TBL] [Abstract][Full Text] [Related]
29. [Effect of Panax japonicus saponin Ⅳa on alleviating nonalcoholic steatohepatitis by regulating miR-17-5p/MFN2 signaling pathway]. Cong LI; Xiao-Hui L; Hai-Rong X; Xiao-Xiao LI; Yue L; Chao-Qi L Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(19):4725-4731. PubMed ID: 33164439 [TBL] [Abstract][Full Text] [Related]
30. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Ren T; Zhu J; Zhu L; Cheng M Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426 [TBL] [Abstract][Full Text] [Related]
31. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction. Guan L; Feng H; Gong D; Zhao X; Cai L; Wu Q; Yuan B; Yang M; Zhao J; Zou Y Exp Gerontol; 2013 Dec; 48(12):1387-94. PubMed ID: 24041487 [TBL] [Abstract][Full Text] [Related]
32. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice. Luo Y; Dong X; Yu Y; Sun G; Sun X J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997 [TBL] [Abstract][Full Text] [Related]
33. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472 [TBL] [Abstract][Full Text] [Related]
34. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525 [TBL] [Abstract][Full Text] [Related]
35. Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis. Chung MY; Mah E; Masterjohn C; Noh SK; Park HJ; Clark RM; Park YK; Lee JY; Bruno RS J Med Food; 2015 Jun; 18(6):648-55. PubMed ID: 25453513 [TBL] [Abstract][Full Text] [Related]
36. [Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride]. Li Y; Li Y; Liu GT Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2096-101. PubMed ID: 15730626 [TBL] [Abstract][Full Text] [Related]
37. A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. Grattagliano I; Diogo CV; Mastrodonato M; de Bari O; Persichella M; Wang DQ; Liquori A; Ferri D; Carratù MR; Oliveira PJ; Portincasa P World J Gastroenterol; 2013 May; 19(20):3007-17. PubMed ID: 23716980 [TBL] [Abstract][Full Text] [Related]
38. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice. Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200 [TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238 [TBL] [Abstract][Full Text] [Related]
40. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease]. Gao H; Xu L; Li D; Guang L; Deng W Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1661-4. PubMed ID: 24273273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]